Applications of Oxolinic Acid in Industrial Manufacturing

As the original producer of oxolinic acid, we supply global B2B partners in precisely regulated industries, addressing specialized needs for purity, regulatory compliance, and process-ready integration. Below, we detail the key industrial application sectors where oxolinic acid consistently demonstrates value within validated production setups, focusing on each segment's distinct regulatory landscape, formulation specifics, downstream workflow, and finished product classes.

1. Veterinary Pharmaceutical Formulations: Aquaculture Antibacterial Agents

Our oxolinic acid supports manufacturers of veterinary drugs for aquaculture, where it remains a core ingredient for combating gram-negative bacterial infections prevalent in finfish farming. Product effectiveness hinges on meeting stringent compliance for residue limits and dosing. Veterinary medicine formulators incorporate the material at defined stages of premix or powder feed additive production, ensuring uniform API distribution and targeted delivery in aquatic environments.

Industry compliance standards

• VICH GL57: Good Manufacturing Practice for APIs
• Regulation (EU) No 37/2010 on pharmacologically active substances
• Japanese Veterinary Pharmacopoeia (JVP)
• China Veterinary Drug Pharmacopoeia

Typical usage ratio

• 0.1–0.5% by weight in medicated premixes or complete feeds; ratios finalized per local residue and withdrawal requirements

Downstream process integration

• Introduced during liquid or dry blending of feed premix batches; further processed via extrusion or pelletizing to ensure stability and bioavailability

Final product types

• Medicated feed for aquaculture species (salmon, trout, tilapia)
• Water-dispersible powder veterinary drugs for aquaculture use
• Oral suspension formulations for fish farms

2. Veterinary Pharmaceutical Formulations: Livestock Oral Dosage Drugs

Livestock oral medication producers use oxolinic acid as a primary active for treating bovine and porcine bacterial infections. It is incorporated with attention to solubility, uniform mixing, and matching withdrawal timelines with each region’s veterinary drug codes. Quality teams audit the integration step to guarantee API concentration reproducibility in mass production and batch traceability from raw powder to dispensable tablet or granule.

Industry compliance standards

• EU Regulation 2019/6 on Veterinary Medicinal Products
• United States FDA: 21 CFR Part 558 (New Animal Drugs for Use in Animal Feeds)
• WHO-GMP for Veterinary Medicines
• Brazil Ministry of Agriculture (MAPA) Registration for Veterinary Drugs

Typical usage ratio

• 0.05–0.2% w/w depending on animal species, administration route, and feed conversion targets

Downstream process integration

• Added in primary mixing of oral powder, granule, or suspension lines; followed by sieving, drying, and tableting steps with in-process content assay checks

Final product types

• Oral powders for swine and cattle
• Granular feed additives for ruminants
• Direct compression tablets for veterinary dosing

3. Analytical Standards and Reference Material Production

Manufacturers of certified reference materials and analytical standards use oxolinic acid of specific grade to produce calibration references for environmental, food safety, and veterinary residue testing. Every batch requires documented purity and traceability, supporting laboratories and governmental agencies in verifying presence and concentration limits in food and water matrices. The raw active is processed at controlled, low concentrations to yield stable, standardized measurement kits.

Industry compliance standards

• ISO 17034:2016 (General requirements for the competence of reference material producers)
• ISO/IEC 17025:2017 (Testing and calibration laboratories)
• Pharmaceutical and Food Residue Analytical Method Guidelines (EU, US FDA, Japan MHLW)

Typical usage ratio

• 1–100 ppm (custom dilution in solvents or matrices, according to detection method sensitivity)

Downstream process integration

• Precisely weighed and dissolved to produce calibration stock solutions; aliquoted and sealed under inert conditions; subjected to batch-level homogeneity and stability testing

Final product types

• Analytical reference stock solutions for LC/MS, GC/MS, and HPLC methods
• Matrix-matched certified reference materials for residue detection
• Quality control test kits for regulatory residue monitoring

4. Research Chemical Supply for Microbiology and Pharmacology Studies

Research institutions and industrial R&D centers source high-purity oxolinic acid as a control compound or primary screening agent in antibacterial, resistance, and pharmacokinetics studies. Application is strictly regulated by compliance with laboratory and ethical protocols. Small-scale formulation aligns with method development needs, and raw material is usually solubilized in culture or assay media before cellular or organism-level testing.

Industry compliance standards

• OECD Principles on Good Laboratory Practice (GLP)
• AAALAC International Accreditation Guidelines for Laboratory Animal Care
• Institutional Review Board (IRB) and Animal Use Protocols

Typical usage ratio

• Commonly 1–100 μg/mL in in vitro assays; variable according to bacterial strain and pharmacological endpoint

Downstream process integration

• Dissolved in aqueous or DMSO solution for inclusion in test media, culture broths, or in vivo dosing vehicles during preclinical study setup

Final product types

• Antibacterial activity test panels
• Reference solutions for microbial resistance profiling
• Pharmacokinetic study samples in academic and contract research projects